Monte Rosa Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$413M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Monte Rosa Therapeutics's estimated annual revenue is currently $9.5M per year.(?)
  • Monte Rosa Therapeutics's estimated revenue per employee is $155,000
  • Monte Rosa Therapeutics's total funding is $413M.

Employee Data

  • Monte Rosa Therapeutics has 61 Employees.(?)
  • Monte Rosa Therapeutics grew their employee count by 281% last year.
  • Monte Rosa Therapeutics currently has 16 job openings.

Small molecule protein degraders are set to reshape the way by which diseases will be treated. \n\nOur rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020. \n\nInitially seeded by Versant Ventures and incubated at Ridgeline Discovery in Basel, and The Institute of Cancer Research in London, Monte Rosa has raised $32.5 million from Versant and New Enterprise Associates. Academic co-founders are Prof. Raj Chopra and Prof. Ian Collins of The Institute for Cancer Research, UK.